(Q87305797)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24534294%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

title

Delivering maximum clinical benefit at an affordable price: engaging stakeholders in cancer care (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24534294%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24534294%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

author name string

Ronan J Kelly

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24534294%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

publication date

14 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24534294%20AND%20SRC:MED&resulttype=core&format=json

Lancet Oncology Commission

8 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24534294%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24534294%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24534294%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

page(s)

e112-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24534294%20AND%20SRC:MED&resulttype=core&format=json

Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions.

8 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Projections of the cost of cancer care in the United States: 2010-2020.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

The anatomy of health care in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Technology assessment for new oncology drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Benchmarks for value in cancer care: an analysis of a large commercial population

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Can England's NHS survive?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Delivering affordable cancer care in high-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

The price tag on progress--chemotherapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Limits on Medicare's ability to control rising spending on cancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Oncogenic targets, magnitude of benefit, and market pricing of antineoplastic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Efficacy does not necessarily translate to cost effectiveness: a case study in the challenges associated with 21st-century cancer drug pricing.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Targeted cancer therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Long-term trends in Medicare payments in the last year of life

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Trends in Medicare payments in the last year of life

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Dying at home--is it better: a narrative appraisal of the state of the science.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

End-of-life care for Medicare beneficiaries with cancer is highly intensive overall and varies widely

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Systematic review of cancer presentations with a median survival of six months or less

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Talking with patients about dying

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Why do our patients get chemotherapy until the end of life?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Impact of payment reform on chemotherapy at the end of life

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Implementation of the Quality Oncology Practice Initiative at a university comprehensive cancer center

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

End-of-life care discussions in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Early specialty palliative care--translating data in oncology into practice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Cost and non-clinical outcomes of palliative care.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Hospice enrollment saves money for Medicare and improves care quality across a number of different lengths-of-stay

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

A randomised controlled trial of hospice care

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Comparing hospice and nonhospice patient survival among patients who die within a three-year window

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Hospice care and survival among elderly patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Hospice eligibility in patients who died in a tertiary care center

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Medical manuscripts impact of hospice enrollment on cost and length of stay of a terminal admission

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

30-day readmissions among seriously ill older adults

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Palliative care consultation teams cut hospital costs for Medicaid beneficiaries.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Inpatient palliative care consults and the probability of hospital readmission

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

American Society of Clinical Oncology 2013 top five list in oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Doc, Shouldn't We Be Getting Some Tests?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

American Society of Clinical Oncology guidance statement: the cost of cancer care

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

First, do no (financial) harm

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

1 reference

7 January 2021

Concrete options and ideas for increasing value in oncology care: the view from one trench

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Cancer drugs in the United States: Justum Pretium--the just price

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Delivering high-quality and affordable care throughout the cancer care continuum

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Reconsidering the Veterans Health Administration: a model and a moment for publicly funded health care delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Effectiveness of a home-based palliative care program for end-of-life

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Impact of an inpatient palliative care team: a randomized control trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Closing the quality loop: facilitating improvement in oncology practice through timely access to clinical performance indicators

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Improving the quality of lung cancer care in Ontario: the lung cancer disease pathway initiative

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Building a medical neighborhood for the medical home

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Oncology patient-centered medical home

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Changing physician incentives for cancer care to reward better patient outcomes instead of use of more costly drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community setting

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Five things physicians and patients should question in hospice and palliative medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Single- vs multiple-fraction radiotherapy for bone metastases from prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Development, implementation, and compliance of treatment pathways in radiation medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Contraindicated use of bevacizumab and toxicity in elderly patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Payment reform options: episode payment is a good place to start

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

The potential for cost savings through bundled episode payments

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Understanding how out-of-pocket expenses, treatment value, and patient characteristics influence treatment choices

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Decision making in oncology: a review of patient decision aids to support patient participation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

Of value: A discussion of cost, communication, and evidence to improve cancer care

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

The elusive path to health care sustainability

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970578-3

7 January 2021

10.1016/S1470-2045(13)70578-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24534294%20AND%20SRC:MED&resulttype=core&format=json

8 March 2020

1 reference